AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7799392
Drug: Various agents
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various agents (gold injections, D-penicillamine, auranofin, antimalarials, azathioprine, sulfasalazine, methotrexate)
Trial: 3259099
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol as a bolus followed by continuous infusion
Trial: 29050464
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no anti-platelet medication)
Trial: 28947466
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GG (LGG) 1010 colony-forming units twice a day for 5 days
Trial: 14733469
Drug: Commercial breath
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial breath analyzer (CBA) measuring volatile sulfur compounds (VSCs) before and after tongue debridement
Trial: 3933675
Drug: Olsalazine 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olsalazine 1 g as a retention enema nightly for two weeks
Trial: 3933675
Drug: Oral olsalazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral olsalazine 2 g daily for two weeks
Trial: 23698186
Drug: Aliskiren (150-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (150-300 mg/d) and Valsartan (160 mg/d)
Trial: 23698186
Drug: Aliskiren (150-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (150-300 mg/d)
Trial: 20443741
Drug: Lip muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lip muscle training with an oral screen
Trial: 17509852
Drug: Flunisolide (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunisolide (inhaled twice a day for 4 weeks)
Trial: 17509852
Drug: Placebo (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inhaled twice a day for 4 weeks)
Trial: 15257185
Drug: Candesartan 8-16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 8-16 mg once daily
Trial: 11427285
Drug: 2.5 microg
RxNorm normalized name: Digoxin 62.5 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 microg dose of hepatitis B vaccine
Trial: 11427285
Drug: 10 microg
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg dose of hepatitis B vaccine
Trial: 9849709
Drug: Glucocorticoid receptors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid receptors in peripheral mononuclear leukocytes (MNL) of PCOS patients
Trial: 9849709
Drug: Glucocorticoid receptors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid receptors in peripheral mononuclear leukocytes (MNL) of healthy women (controls)
Trial: 8002670
Drug: Oral potassium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral potassium citrate therapy (600 mEq/day)
Trial: 2507028
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment (weight reduction, sodium restriction, decreased alcohol intake)
Trial: 2507028
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment (atenolol as first choice)
Trial: 12137822
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of anesthesia used for groups 2 and 3 (group 4)
Trial: 7775629
Drug: 30 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 micrograms EE plus 3 mg DRSP (group A)
Trial: 7775629
Drug: 20 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms EE plus 3 mg DRSP (group B)
Trial: 7775629
Drug: 15 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 micrograms EE plus 3 mg DRSP (group C)
Trial: 7457946
Drug: Fentanyl citrate
RxNorm normalized name: Fentanyl Citrate
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl citrate (0.0015, 0.003, 0.006 mg/kg)
Trial: 7457946
Drug: Morphine chlorhydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine chlorhydrate (0.100, 0.150, 0.200 mg/kg)
Trial: 7457946
Drug: Morphine chlorhydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine chlorhydrate
Trial: 31051279
Drug: MF59-adjuvanted seasonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted seasonal trivalent inactivated influenza vaccine (aIIV3)
Trial: 31051279
Drug: Non-adjuvanted inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-adjuvanted inactivated influenza vaccine (IIV3)
Trial: 22082794
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of all training methods (A)
Trial: 15217304
Drug: Intravenous oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous oxycodone (0.1 mg/kg)
Trial: 15217304
Drug: Intramuscular oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular oxycodone (0.1 mg/kg)
Trial: 15217304
Drug: Buccal oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal oxycodone (0.1 mg/kg)
Trial: 15217304
Drug: Gastric oxycodone
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric oxycodone (0.1 mg/kg)
Trial: 9611670
Drug: Ketamine (0.12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.12 mg/kg bolus and 0.65 mg/kg/hour)
Trial: 7922759
Drug: 1,200 mg
RxNorm normalized name: lecithin 1,200 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,200 mg of artemisinine daily for 5 days
Trial: 7922759
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg of mefloquine plus 45 mg of primaquine as a single dose
Trial: 29393818
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of 0.75% ropivacaine (group II)
Trial: 29393818
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of 0.75% ropivacaine with 100 μg fentanyl (group III)
Trial: 28594758
Drug: Early insertion
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early insertion of etonogestrel implant (up to 48 hours postpartum)
Trial: 28594758
Drug: Conventional insertion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional insertion of etonogestrel implant (at 6 weeks postpartum)
Trial: 28594758
Drug: Early insertion
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early insertion of etonogestrel implant
Trial: 28594758
Drug: Conventional insertion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional insertion of etonogestrel implant
Trial: 25268386
Drug: Sarpogrelate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate (100 mg bid; total dose of 200 mg)
Trial: 25268386
Drug: Sarpogrelate pretreatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate pretreatment (100 mg tid for three days)
Trial: 25268386
Drug: Metoprolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100 mg) alone
Trial: 24030452
Drug: Nonspecific EAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonspecific EAP treatments, treated once a week for 8 weeks after a 2-week run-in period.
Trial: 21935818
Drug: Trigger point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trigger point injection combined with stabilization splint (SS) therapy
Trial: 21935818
Drug: Stabilization splint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stabilization splint (SS) therapy
Trial: 12228010
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) by needle
Trial: 12228010
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) by jet injection (Biojector®)
Trial: 12228010
Drug: Intramuscular/intradermally (ID)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular/intradermally (ID) by jet injection
Trial: 11910660
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen 0.625 mg, selective estrogen receptor modulator (two doses), or placebo
Trial: 6800809
Drug: Antipyrine (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine (1200 mg daily for 14 days)
Trial: 6800809
Drug: Phenobarbital (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital (100 mg daily for 14 days)
Trial: 6800809
Drug: Rifampicin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (1200 mg daily for 14 days)
Trial: 6800809
Drug: Rifampicin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (1200 mg daily for 14 days) with injected 125I-T4
Trial: 31483961
Drug: SAGE-217 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAGE-217 (30 mg once daily)
Trial: 25495357
Drug: Methylphenidate (0.30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (0.30 mg/kg)
Trial: 25495357
Drug: Methylphenidate (0.60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (0.60 mg/kg)
Trial: 20031860
Drug: Monthly angina
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly angina (score 61 to 99)
Trial: 20031860
Drug: Weekly angina
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly angina (score 31 to 60)
Trial: 20031860
Drug: Daily angina
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily angina (score 0 to 30)
Trial: 18187379
Drug: CI >2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CI >2.4 L/min per m2
Trial: 10695642
Drug: Venlafaxine, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine, 300 mg/day
Trial: 8251268
Drug: Alfentanil 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 100 micrograms kg‐1 every 5 min to a total dose of 500 micrograms kg‐1
Trial: 8251268
Drug: Fentanyl 10
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 10 micrograms kg‐1 every 7 min to a total dose of 50 micrograms kg‐1
Trial: 8251268
Drug: Morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1 mg kg‐1 for induction and 0.5 mg kg‐1 every 15 min to a total dose of 3 mg kg‐1
Trial: 29226862
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg encapsulated generic losartan once daily for 12 months
Trial: 17641562
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine acupuncture
Trial: 15508021
Drug: Fentanyl self-administration
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl self-administration (SA) 1.5 mg/70 kg
Trial: 15508021
Drug: Fentanyl passive
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl passive administration (PA) 1.5 mg/70 kg
Trial: 8543502
Drug: Meropenem 40
RxNorm normalized name: Meropenem
DrugBank: Meropenem (DB00760)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meropenem 40 mg/kg 8-hourly, up to a maximum of 6 g/day (n = 28)
Trial: 1674589
Drug: gp160 vaccine
RxNorm normalized name: Gp160 Vaccine
DrugBank: VaxSyn (DB17827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gp160 vaccine administered on days 0, 30, and 120 or on days 0, 30, 60, 120, 150, and 180
Trial: 1674589
Drug: gp160 vaccine
RxNorm normalized name: Gp160 Vaccine
DrugBank: VaxSyn (DB17827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gp160 vaccine with six injections
Trial: 1674589
Drug: gp160 vaccine
RxNorm normalized name: Gp160 Vaccine
DrugBank: VaxSyn (DB17827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gp160 vaccine with three injections
Trial: 23089085
Drug: Acceptance based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance based mirror exposure therapy (A-MET)
Trial: 23089085
Drug: Non-directive body
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-directive body image therapy (ND)
Trial: 20715729
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg) and tropisetron
Trial: 11144934
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily administration of valproate delayed release mini-tablets (VPA mrt.)
Trial: 11144934
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily administration of valproate delayed release mini-tablets (VPA mrt.)
Trial: 11144934
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment with valproate delayed release mini-tablets (VPA mrt.)
Trial: 1459268
Drug: Ultrashort regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrashort regimen of gonadotropin-releasing hormone agonist (GnRH-a)
Trial: 1459268
Drug: Short regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short regimen of gonadotropin-releasing hormone agonist (GnRH-a)
Trial: 6321310
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg X 2/day/7 days)
Trial: 6321310
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg X 2/day/7 days)
Trial: 31971089
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (4000 IU daily for 4 weeks)
Trial: 31495242
Drug: Jessner's solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jessner's solution peeling
Trial: 31495242
Drug: Dermapen and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermapen and Jessner's solution peeling
Trial: 30145120
Drug: Lung cancer
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lung cancer screening using low-dose CT with model incorporating nodule features and patient characteristics
Trial: 26836927
Drug: Azithromycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (250 mg three times a week for 8 weeks)
Trial: 18330080
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) 20 mg/m2/day orally
Trial: 18330080
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) plus 13-cis-retinoic acid (RA) 1 mg/kg/day orally
Trial: 18330080
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) plus Interferon alpha-2a (IFN alpha-2a) 3 MU thrice a week intramuscular
Trial: 8595082
Drug: Test preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test preparation T (10 mg nifedipine)
Trial: 8595082
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation R (20 mg nifedipine)
Trial: 327749
Drug: Stilbestrol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stilbestrol treatment
Trial: 29029278
Drug: Delafloxacin 300mg
RxNorm normalized name: DELAFLOXACIN 300MG/VIL INJ
DrugBank: Delafloxacin (DB11943)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Delafloxacin 300mg administered intravenously twice daily for 5-14 days
Trial: 29029278
Drug: Vancomycin 15mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin 15mg/kg plus aztreonam 2g administered intravenously twice daily for 5-14 days
Trial: 12798637
Drug: C4-V3 polypeptide
RxNorm normalized name: SH-polypeptide-42
DrugBank: Interleukin-7 (DB11997)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C4-V3 polypeptide vaccine emulsified in incomplete Freund's
Trial: 12798637
Drug: Other vaccines
RxNorm normalized name: OTHER VACCINES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other vaccines and adjuvants studied
Trial: 1680150
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oral folic acid
Trial: 6336928
Drug: 12% lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12% lactate lotion
Trial: 6336928
Drug: Nonlactated emollient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonlactated emollient lotion
Trial: 26912003
Drug: Mifepristone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (600 mg/day for 7 days, then 400 mg/day for 7 days)
Trial: 26912003
Drug: Placebo (equivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (equivalent number of placebo tablets for 14 days)
Trial: 25085076
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with docetaxel, cisplatin, and 5‐fluorouracil (TPF)
Trial: 25085076
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment with surgery and postoperative radiation
Trial: 768533
Drug: Aspirin-phenacetin-caffeine (APC)
RxNorm normalized name: aspirin / butalbital / caffeine / phenacetin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin-phenacetin-caffeine (APC) plus codeine
Trial: 19843482
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg IV q6h
Trial: 19843482
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg IV q6h
Trial: 18046889
Drug: Oral mucolytics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mucolytics (daily therapy for at least 2 months)
Trial: 18046889
Drug: Tiotropium and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium and inhaled corticosteroids (ICS)
Trial: 18046889
Drug: Mucolytics
RxNorm normalized name: MUCOLYTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucolytics
Trial: 8990451
Drug: Methotrexate, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate, 1 mg/kg intramuscularly, within 24 hours postoperatively
Trial: 8250455
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (streptokinase, urokinase, rt-PA) followed by balloon angioplasty
Trial: 3291526
Drug: 1 microgram
RxNorm normalized name: Alfacalcidol 1 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 microgram dDAVP administered im every 12 h (N = 6)
Trial: 3291526
Drug: 2 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 micrograms dDAVP administered im every 12 h (N = 5)
Trial: 3291526
Drug: 4 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 micrograms dDAVP administered im every 12 h (N = 4)
Trial: 28266875
Drug: Levofloxacin-concomitant therapy
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin-concomitant therapy for 10 days (n=55)
Trial: 28266875
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (n=59)
Trial: 20135899
Drug: Prophylactic antidepressants
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antidepressants
Trial: 21355649
Drug: Video-feedback intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Video-feedback intervention to promote positive parenting-child care (VIPP-CC)
Trial: 16209160
Drug: Niacinamide-containing facial
RxNorm normalized name: Niacinamide
DrugBank: Nicotinamide (DB02701)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Niacinamide-containing facial moisturizer applied to the face and one forearm twice daily for 4 weeks
Trial: 9881074
Drug: Postoperative radiochemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiochemotherapy (RCT) + chemotherapy (CT)
Trial: 7708069
Drug: Lipiodol chemoembolization
RxNorm normalized name: doxorubicin hydrochloride liposome Injection [LipoDox]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipiodol chemoembolization (70 mg of cisplatin, 10 ml of lipiodol, and gelatin‐sponge particles delivered through the hepatic artery)
Trial: 7708069
Drug: Conservative management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative management (treatment of complications and pain)
Trial: 2706885
Drug: Heparin lock
RxNorm normalized name: Heparin Lock Flush
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin lock catheter (n=17)
Trial: 2706885
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous line (n=22)